MetLife Investment Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-125,461
| Closed | -$3.72M | – | 2846 |
|
2023
Q4 | $3.72M | Sell |
125,461
-2,433
| -2% | -$72.1K | 0.03% | 649 |
|
2023
Q3 | $2.03M | Hold |
127,894
| – | – | 0.02% | 897 |
|
2023
Q2 | $2.41M | Buy |
127,894
+17,450
| +16% | +$329K | 0.02% | 857 |
|
2023
Q1 | $424K | Hold |
110,444
| – | – | ﹤0.01% | 1745 |
|
2022
Q4 | $548K | Hold |
110,444
| – | – | ﹤0.01% | 1585 |
|
2022
Q3 | $528K | Buy |
110,444
+9,667
| +10% | +$46.2K | ﹤0.01% | 1597 |
|
2022
Q2 | $453K | Sell |
100,777
-7,699
| -7% | -$34.6K | ﹤0.01% | 1731 |
|
2022
Q1 | $516K | Buy |
108,476
+38,679
| +55% | +$184K | ﹤0.01% | 1752 |
|
2021
Q4 | $518K | Buy |
69,797
+10,556
| +18% | +$78.3K | ﹤0.01% | 1488 |
|
2021
Q3 | $336K | Sell |
59,241
-14,457
| -20% | -$82K | ﹤0.01% | 1762 |
|
2021
Q2 | $486K | Hold |
73,698
| – | – | ﹤0.01% | 1591 |
|
2021
Q1 | $597K | Buy |
73,698
+14,366
| +24% | +$116K | 0.01% | 1424 |
|
2020
Q4 | $383K | Buy |
59,332
+3,331
| +6% | +$21.5K | ﹤0.01% | 1611 |
|
2020
Q3 | $202K | Sell |
56,001
-21,499
| -28% | -$77.4K | ﹤0.01% | 1862 |
|
2020
Q2 | $357K | Hold |
77,500
| – | – | ﹤0.01% | 1563 |
|
2020
Q1 | $264K | Buy |
77,500
+17,754
| +30% | +$60.5K | ﹤0.01% | 1545 |
|
2019
Q4 | $305K | Hold |
59,746
| – | – | ﹤0.01% | 1737 |
|
2019
Q3 | $145K | Hold |
59,746
| – | – | ﹤0.01% | 2127 |
|
2019
Q2 | $130K | Hold |
59,746
| – | – | ﹤0.01% | 2261 |
|
2019
Q1 | $162K | Hold |
59,746
| – | – | ﹤0.01% | 2089 |
|
2018
Q4 | $287K | Hold |
59,746
| – | – | ﹤0.01% | 1708 |
|
2018
Q3 | $566K | Hold |
59,746
| – | – | 0.01% | 1457 |
|
2018
Q2 | $581K | Buy |
59,746
+13,727
| +30% | +$133K | 0.01% | 1321 |
|
2018
Q1 | $484K | Hold |
46,019
| – | – | 0.01% | 1387 |
|
2017
Q4 | $295K | Buy |
+46,019
| New | +$295K | ﹤0.01% | 1720 |
|